Lv1
10 积分 2024-05-14 加入
Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese Volunteers
20天前
已完结
Anaemia in CKD 1-5
4个月前
已完结
A Model-Informed Approach to Accelerate the Clinical Development of Janagliflozin, an Innovative SGLT2 Inhibitor
4个月前
已完结
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model
6个月前
已完结
Efficacy and Safety of Biosimilar Romiplostim in Immune Thrombocytopenic Purpura : Single Centre Retrospective Data Analysis
6个月前
已完结
Biosimilars in India; current status and future perspectives
6个月前
已完结
皖公网安备34019202002308
